文献速递瓣膜病与结构性心脏病

生物瓣与机械瓣感染性心内膜炎风险的系统综述与荟萃分析

Endocarditis risk with bioprosthetic and mechanical valves: systematic review and meta-analysis.
PubMed 文献 · Heart · 2020-05-29

结果显示生物瓣患者感染性心内膜炎风险高于机械瓣患者(OR 1.59,95%CI 1.35–1.88,p<0.001),绝对风险降低9/1000(95%CI 6–14)。

要点

  • 生物瓣患者感染性心内膜炎风险高于机械瓣患者(OR 1.59,95%CI 1.35–1.88)。
  • 绝对风险降低9/1000(95%CI 6–14),异质性低(I2=0%)。
  • 随访时间差异未改变合并风险估计(p=0.788)。

核心结论

  • 生物瓣可能与更高的感染性心内膜炎风险相关,该数据有助于个体化决策时讨论。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、Cochrane、EMBASE、Scopus和Web of Science至2018年4月。
  • 纳入随机试验或倾向匹配观察性研究,比较左侧主动脉瓣和二尖瓣生物瓣与机械瓣。

主要发现

  • 生物瓣患者感染性心内膜炎风险高于机械瓣患者(OR 1.59,95%CI 1.35–1.88,p<0.001)。
  • 绝对风险降低9/1000(95%CI 6–14)。
  • 纳入研究异质性低(I2=0%)。
  • 排除权重最大的研究后结果不变(OR 1.57,95%CI 1.14–2.17,p=0.006)。
  • 随访时间对感染性心内膜炎发生率的荟萃回归无统计学意义(p=0.788)。

临床怎么用

  • 在年轻患者中权衡生物瓣与机械瓣时,应将感染性心内膜炎风险纳入个体化讨论。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Bioprosthetic valves are being used with increased frequency for valve replacement, with controversy regarding risk:benefit ratio compared with mechanical valves in younger patients. However, prior studies have been too small to provide comparative estimates of less common but serious adverse events such as infective endocarditis. We aimed to compare the incidence of infective endocarditis between bioprosthetic valves and mechanical valves. METHODS: We searched PubMed, Cochrane, EMBASE, Scopus and Web of Science from inception to April 2018 for studies comparing left-sided aortic and mitral bioprosthetic to mechanical valves for randomised trials or observational studies with propensity matching. We used random-effects model for our meta-analysis. Our primary outcome of interest was the rate of infective endocarditis at follow-up. RESULTS: 13 comparison groups with 43 941 patients were included. Mean age was 59±7 years with a mean follow-up of 10.4±5.0 years. Patients with bioprosthetic valves had a higher risk of infective endocarditis compared with patients receiving mechanical valves (OR 1.59, 95% CI 1.35 to 1.88, p<0.001) with an absolute risk reduction of 9 per 1000 (95% CI 6 to 14). Heterogeneity within the included studies was low (I2=0%). Exclusion of the study with maximum weight did not change the results of the analysis (OR 1.57, 95% CI 1.14 to 2.17, p=0.006). A meta-regression of follow-up time on incidence of infective endocarditis was not statistically significant (p=0.788) indicating difference in follow-up times did not alter the pooled risk of infective endocarditis. CONCLUSIONS: Bioprosthetic valves may be associated with a higher risk of infective endocarditis. These data should help guide the discussion when deciding between bioprosthetic and mechanical valves in individual patients.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Anantha-Narayanan M, Reddy YNV, Sundaram V, et al. Endocarditis risk with bioprosthetic and mechanical valves: systematic review and meta-analysis. Heart. 2020. PMID: 32471905. doi:10.1136/heartjnl-2020-316718

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。